Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Antigens, Neoplasm - immunology"" wg kryterium: Temat


Tytuł :
Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination
Autorzy :
Romero, P.
Cerottini, J.C.
Speiser, D.E.
Pokaż więcej
Temat :
Antigens, Neoplasm/immunology
Cancer Vaccines/immunology
Clinical Trials, Phase I as Topic
Humans
Neoplasms/therapy
T-Lymphocytes, Cytotoxic/immunology
Vaccination
Źródło :
Cancer Immunology, Immunotherapy, vol. 53, no. 3, pp. 249-255
Opis pliku :
application/pdf
Tytuł :
STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity.
Autorzy :
Demaria, O.
De Gassart, A.
Coso, S.
Gestermann, N.
Di Domizio, J.
Flatz, L.
Gaide, O.
Michielin, O.
Hwu, P.
Petrova, T.V.
Martinon, F.
Modlin, R.L.
Speiser, D.E.
Gilliet, M.
Pokaż więcej
Temat :
Interferon alpha-beta
Endothelial Cells
Experimental
Immunity
Mice
Tumor-Infiltrating
Dendritic Cells
Membrane Proteins
Intralesional
CD8-Positive T-Lymphocytes
Interferon Type I
type I IFNs
Animals
Dose-Response Relationship
Injections
Antigens, Neoplasm/immunology
CD8-Positive T-Lymphocytes/immunology
CTLA-4 Antigen/immunology
Cell Proliferation/drug effects
Dendritic Cells/drug effects
Dendritic Cells/immunology
Disease Models, Animal
Dose-Response Relationship, Immunologic
Endothelial Cells/drug effects
Endothelial Cells/metabolism
Injections, Intralesional
Interferon Type I/metabolism
Lymphocytes, Tumor-Infiltrating/drug effects
Lymphocytes, Tumor-Infiltrating/immunology
Melanoma/immunology
Melanoma/pathology
Melanoma, Experimental/immunology
Melanoma, Experimental/pathology
Membrane Proteins/metabolism
Mice, Inbred C57BL
Neoplasms/immunology
Neoplasms/pathology
Nucleotides, Cyclic/administration & dosage
Nucleotides, Cyclic/pharmacology
Receptor, Interferon alpha-beta/metabolism
Signal Transduction/drug effects
Lymphocytes
Cell Proliferation
Signal Transduction
Inbred C57BL
Melanoma
STING
Antigens
CTLA-4 Antigen
antitumor immunity
Disease Models
Immunologic
Biological Sciences
tumor endothelial cells
CD8 T cells
Receptor
Animal
Neoplasm
Neoplasms
Nucleotides
Cyclic
Źródło :
Proceedings of the National Academy of Sciences of the United States of America, vol 112, iss 50
Proceedings of the National Academy of Sciences of the United States of America, vol. 112, no. 50, pp. 15408-15413
Demaria, O; De Gassart, A; Coso, S; Gestermann, N; Di Domizio, J; Flatz, L; et al.(2015). STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 112(50), 15408 - 15413. doi: 10.1073/pnas.1512832112. UCLA: Retrieved from: http://www.escholarship.org/uc/item/84j2233p
Demaria, O; De Gassart, A; Coso, S; Gestermann, N; Di Domizio, J; Flatz, L; et al.(2015). STING activation of tumor endothelial cells initiates spontaneous and therapeutic antitumor immunity. Proceedings of the National Academy of Sciences of the United States of America, 112(50), 15408 - 15413. doi: 10.1073/pnas.1512832112. UCLA: Retrieved from: http://www.escholarship.org/uc/item/7vf5310v
Opis pliku :
application/pdf
Tytuł :
NY-ESO-1-Specific Circulating CD4+ T Cells in Ovarian Cancer Patients Are Prevalently TH1 Type Cells Undetectable in the CD25+FOXP3+Treg Compartment
Autorzy :
Redjimi, N.
Duperrier-Amouriaux, K.
Raimbaud, I.
Luescher, I.
Dojcinovic, D.
Classe, J.M.
Berton-Rigaud, D.
Frenel, J.S.
Bourbouloux, E.
Valmori, D.
Ayyoub, M.
Pokaż więcej
Temat :
Adenocarcinoma, Clear Cell/immunology
Adenocarcinoma, Clear Cell/metabolism
Adenocarcinoma, Mucinous/immunology
Adenocarcinoma, Mucinous/metabolism
Adult
Aged
Antigens, Neoplasm/immunology
Antigens, Neoplasm/metabolism
CD4-Positive T-Lymphocytes/immunology
CD4-Positive T-Lymphocytes/metabolism
Cystadenocarcinoma, Serous/immunology
Cystadenocarcinoma, Serous/metabolism
Female
Forkhead Transcription Factors/metabolism
Humans
Interleukin-10/metabolism
Interleukin-17/metabolism
Interleukin-2 Receptor alpha Subunit/metabolism
Lymphocyte Count
Major Histocompatibility Complex
Membrane Proteins/immunology
Membrane Proteins/metabolism
Middle Aged
Ovarian Neoplasms/immunology
Ovarian Neoplasms/metabolism
T-Lymphocytes, Regulatory/immunology
T-Lymphocytes, Regulatory/metabolism
Th1 Cells/immunology
Th1 Cells/metabolism
Research Article
Biology
Tumor Immunology
Immune Physiology
Ovarian Cancer
Immune Cells
Medicine
Immunity
Antigens
Anatomy and Physiology
Oncology
Gynecological Tumors
Immunologic Subspecialties
T Cells
Immune Response
Clinical Immunology
Science
Immunoregulation
Cancers and Neoplasms
Immunology
Źródło :
PLos One, vol. 6, no. 7, pp. e22845
PLoS ONE, Vol 6, Iss 7, p e22845 (2011)
Opis pliku :
application/pdf
Tytuł :
BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
Autorzy :
Derré, Laurent
Rivals, Jean-Paul
Jandus, Camilla
Pastor, Sonia
Rimoldi, Donata
Romero, Pedro
Michielin, Olivier
Olive, Daniel
Speiser, Daniel E
Pokaż więcej
Temat :
Research Article
Animals
Antigens, CD/physiology
Antigens, Neoplasm/immunology
Apoptosis Regulatory Proteins/physiology
CD8-Positive T-Lymphocytes/immunology
COS Cells
Cell Line, Tumor
Cercopithecus aethiops
Humans
Interferon-gamma/biosynthesis
Lymphocyte Activation
MART-1 Antigen
Melanoma/immunology
Melanoma/therapy
Neoplasm Proteins/immunology
Oligodeoxyribonucleotides/pharmacology
Receptors, Immunologic/physiology
Receptors, Tumor Necrosis Factor, Member 14/physiology
Vaccination
Źródło :
Journal of Clinical Investigation, vol. 120, no. 1, pp. 157-167
Derré, Laurent; Rivals, Jean-Paul; Jandus, Camilla; Pastor, Sonia; Rimoldi, Donata; Romero, Pedro; Michielin, Olivier; Olive, Daniel; Speiser, Daniel E (2010). BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination. Journal of clinical investigation, 120(1), pp. 157-67. Ann Arbor, Mich.: American Society for Clinical Investigation 10.1172/JCI40070
Opis pliku :
application/pdf

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies